Technical Analysis for RGNX - REGENXBIO Inc.

Grade Last Price % Change Price Change
F 35.87 1.50% 0.53
RGNX closed up 1.5 percent on Thursday, April 15, 2021, on 49 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.
Earnings due: May 5
*** please verify all earnings dates ***

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Up
Historical RGNX trend table...

Date Alert Name Type % Chg
Shooting Star Candlestick Bearish 0.00%
Lizard Bearish Bearish Day Trade Setup 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Crossed Above 20 DMA Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Doji - Bearish? Reversal 0.00%
Up 3 Days in a Row Strength 0.00%
20 DMA Resistance Bearish 1.50%
Wide Bands Range Expansion 6.28%
Older End-of-Day Signals for RGNX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Rose Above 20 DMA about 18 hours ago
Rose Above Previous Day's High about 18 hours ago
Up 2% about 18 hours ago
Up 1% about 18 hours ago
20 DMA Resistance 1 day ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

REGENXBIO Inc. Description

REGENXBIO Inc., a biotechnology company, focuses on the development, commercialization, and licensing of recombinant adeno-associated virus (AAV) gene therapy. The company's development programs include RGX-501, a product candidate for the treatment of homozygous familial hypercholesterolemia, which uses the AAV8 vector to deliver the human low-density lipoprotein receptor gene to liver cells; and RGX-111, a product candidate for the treatment of Mucopolysaccharidosis Type I, which uses the AAV9 vector to deliver the human a-l-iduronidase gene to the central nervous system. Its programs also include RGX-121, a product candidate for the treatment of Mucopolysaccharidosis Type II; RGX-314, a product candidate for the treatment of wet age-related macular degeneration; and RGX-321, a product candidate for the treatment of X-linked retinitis pigmentosa. The company was formerly known as REGENX Biosciences, LLC and changed its name to REGENXBIO Inc. in September 2014. REGENXBIO Inc. was founded in 2008 and is headquartered in Rockville, Maryland.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biology Emerging Technologies Genetics Molecular Biology Gene Therapy Macular Degeneration Medical Genetics Related Macular Degeneration Cholesterol Applied Genetics Wet Age Related Macular Degeneration Gene Delivery Lipoprotein Retinitis Hypercholesterolemia Retinitis Pigmentosa Adeno Associated Virus Mucopolysaccharidosis Mozy Rgx Homozygous Familial Hypercholesterolemia Iduronidase Mucopolysaccharidosis Type X Linked Retinitis Pigmentosa

Is RGNX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 50.26
52 Week Low 25.925
Average Volume 348,300
200-Day Moving Average 36.55
50-Day Moving Average 39.86
20-Day Moving Average 35.44
10-Day Moving Average 34.79
Average True Range 1.77
ADX 28.04
+DI 14.69
-DI 21.00
Chandelier Exit (Long, 3 ATRs ) 37.15
Chandelier Exit (Short, 3 ATRs ) 37.48
Upper Bollinger Band 39.26
Lower Bollinger Band 31.62
Percent B (%b) 0.56
BandWidth 21.56
MACD Line -1.37
MACD Signal Line -1.71
MACD Histogram 0.3472
Fundamentals Value
Market Cap 1.34 Billion
Num Shares 37.4 Million
EPS -1.36
Price-to-Earnings (P/E) Ratio -26.39
Price-to-Sales 9.50
Price-to-Book 3.33
PEG Ratio 0.26
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 36.78
Resistance 3 (R3) 36.85 36.60 36.63
Resistance 2 (R2) 36.60 36.37 36.57 36.58
Resistance 1 (R1) 36.24 36.23 36.11 36.17 36.53
Pivot Point 35.99 35.99 35.93 35.96 35.99
Support 1 (S1) 35.63 35.76 35.51 35.57 35.21
Support 2 (S2) 35.38 35.62 35.35 35.16
Support 3 (S3) 35.02 35.38 35.11
Support 4 (S4) 34.96